A journey towards the identification of novel therapeutical strategies for advanced cholangiocarcinoma with IDH1 mutations 

Serra Camprubí, Queralt (Date of defense: 2023-07-27)

[eng] The field of cancer treatment has shifted towards personalized medicine, driven by advancements in understanding molecular and genetic abnormalities and identifying specific targets within cancer cells. Precision ...